Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Ardent Health Partners, Inc. in the offering, and Latham & Walkins represented the underwriters. Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents. IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the placement agents in the offering. UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement...
You must be a Standard 1 Year member to access this content.
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering. AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Zentalis in the offering, and Cooley represented the underwriters. Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) announced the pricing of an underwritten offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...
You must be a Standard 1 Year member to access this content.
